[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:anaplastic-ependymoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":22,"states":23},"Anaplastic Ependymoma",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05278208","Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:21.216897Z","2026-07-24T01:27:14.928126Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT04541082","Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms",[19],"Phase 1","2026-08-26T02:18:37.277498Z","2026-05-05T02:43:29.163334Z",[],[]]